To our knowledge, we are the first to describe the effect of BC paracrine signaling on human osteoclast activity under β2-AR agonism in vitro, and therefore, species-related differences should be accounted for when comparing with in vivo studies. The gene discussed is ADRB2; the disease is breast cancer.